Vaxxinova Norway

Industry

Diagnostics, Fishery & aquaculture, Seeds & genetics, Veterinary

Topics

Animal & aquaculture vaccines, Livestock & poultry production/genetics

Role

Not classified

Products: Licensed and autogenous vaccines; Diagnostic services; VAXXON® poultry vaccines; Avishield® poultry vaccines; VAXXON®SRP® Klebsiella; VAXXON®SRP® Salmonella; Aqua vaccines; Swine vaccines; Autogenous vaccines; More Vaxxinova solutions

Applications

Production animals including poultry, aqua, cattle and swine · Cattle breeding · Dairy farming · Beef farming · Livestock · Fish · Tilapia farming

Customers & partners

EW Group · Biovet-Vaxxinova · Erich Wesjohann Group

Production sites

Netherlands — Autogenous and licensed vaccines, diagnostic services · Brazil · Canada · Chile · Colombia · Croatia · Italy · Germany · Japan · Jordan · Norway · South Africa

Products (website)

Licensed and autogenous vaccines · Diagnostic services · VAXXON® poultry vaccines · Avishield® poultry vaccines · VAXXON®SRP® Klebsiella · VAXXON®SRP® Salmonella · Aqua vaccines · Swine vaccines · Autogenous vaccines · More Vaxxinova solutions · All Atack — Antiparasitic for cattle. · SRP® Technology — A patented method for producing vaccines by utilizing Siderophore Receptor and Porin proteins.

R&D facilities

Choka Laboratory

Read from the company's own website: about · products · production · quality · rnd · leadership · contact · topic

• 2026-06-30 Vaxxinova is Granted Regulatory Approval for Vaxxon® Yersinia vet - Vaxxinova
  Vaxxinova Norway (Vaxxinova Norway and Chile) has achieved a regulatory milestone with Vaxxon Yersinia vet receiving approval from the Norwegian Medical Products Agency (NOMA) for Atlantic salmon. The approval marks the company’s first registered vaccine for …
• 2026-07-07 A milestone for Vaxxinova in cold-water aquaculture vaccines - Vaxxinova
  Vaxxinova Norway (Bergen) announces that NoMA has granted marketing authorization for Vaxxon Yersinia vet, the first licensed cold-water aquaculture oil-based vaccine in Europe, developed with collaboration across Bergen (NO) and other European sites. It also …
• 2026-07-07 News - Vaxxinova
  Vaxxinova Norway has announced regulatory approvals for its Vaxxon Yersinia vet vaccine, first receiving NoMA and then NOK (NOMA) clearance in Norway for an oil-based inactivated vaccine targeting Yersinia ruckeri to prevent Enteric Redmouth Disease in …
• 2026-06-26 Har fått godkjenning for vaksine mot yersiose
  Vaxxinova Norway has received regulatory approval from the Norwegian Medicines Agency (DMP) for its vaccine Vaxxon Yersinia vet, an inactivated vaccine for Atlantic salmon targeting Yersinia ruckeri (yersiniose/ERM). This marks the company's first registered …
• 2025-05-15 Vaxxinova Norway AS opplever negativt resultat for 14. år på rad
  Vaxxinova Norway AS in Bergen reports a negative result for the 14th consecutive year according to its latest accounts.
• 2025-03-24 Aquatic Health Innovation: Vaxxinova Advances in Tenacibaculosis Vaccine Development - Vaxxinova
  Vaxxinova Norway (Bergen/Tromsø context) is actively advancing a Tenacibaculum finnmarkense vaccine, presenting promising prototype protection at the Frisk Fisk conference and collaborating with Cermaq Group and the University of Tromsø as part of a broader …

Ownership & investors 1

Similar companies

PHARMAQ part of Zoetis · Benchmark Vaccines Limited · AQUATRECK ANIMAL HEALTH S.L · ACUIPHARMA AQUACULTURE HEALTH SL · STIM · SAN Vet Europe · Aquatic Biologicals · CZ Vaccines